Fidaxomicin

Restricted
C difficile risk
None
Oral Bioavailability
N/A

Spectrum Of Activity

Dosing

Not approved for usage under 18 years of age. Contact Infectious Diseases practitioner for more specific guidance.

No dosage adjustment required

Must be approved for usage by Infectious Diseases and Pharmacy to confirm supply

General Information

C. difficile colitis refractory to first line therapies and/or re-infection not responding to conventional therapies.

  • ¬†GI disturbance

  • ¬†Cytopenias

  • ¬†Hypersensitivity: facial, tongue or throat swelling

Consult Infectious Diseases prior to usage

Antimicrobial class: Specialized anti-C. difficile macrocyclic agent

Pregnancy category: B

Urine penetration: None

Lung penetration: None

CSF penetration: None

Biliary penetration: None